During the past decade, Richard M.Kastelic MD and Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Richard M.Kastelic MD and Associates" are "Colorectal Cancer" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Richard M.Kastelic MD and Associates" in a lesser frequency.

Most popular intervention types in "Richard M.Kastelic MD and Associates" are "Drug" (2 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials), "Blood Sample Collection" (1 trials) and "Colonoscopy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Richard M.Kastelic MD and Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Richard M.Kastelic MD and Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Richard M.Kastelic MD and Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Richard M.Kastelic MD and Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".